Search results for: 'biologics antibody reagents us'

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

This research service provides a comprehensive overview of the US C5ISR industry, offering industry segmentation, funding/spending analysis, and competitive assessment. The C5ISR industry, based on platform type, is categorized into: 1. Computers 2. Command and Control (C2) 3. Communications 4. Cyber 5. Intelligence, Surveillance, and Reconnaissan...

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as assay components for detection and quantification of particular targets within a sample. Provided within the study is a detailed history and market o...

In this research service, Frost & Sullivan overviews the US Defense Information Systems Agency s (DISA) budget between FY2023 and FY2029. It outlines the agency s funding distribution for each account as well as a forecast with future spending estimates. It also includes an analysis of contract awards share. Additionally, the study highlights th...

This research examines the European PCR reagent markets for research application and clinical diagnostics in terms of the challenges faced by market participants and drivers and restraints in the industry. It also describes the end user's experience who incorporate PCR in their experimental plan. It provides a detailed study on market share analysi...

01 Feb 2022  |  North America  |  Market Research

US DoD Helicopters Growth Opportunities

Sustainment and New-build Advanced Program Developments Will Drive Growth Opportunities

Infographics

×

This research service focuses on the US Department of Defense (DoD) FY 2022 budget request for helicopters. An analysis of research, development, test, and evaluation (RDT&E); procurement; operations and maintenance (O&M); and other services is also presented. Helicopter contract activity and participating companies for FY 2021 are included. The...

As enterprise adoption of AI enters a more demanding phase, the source of competitive advantage is shifting. In 2026, success is no longer determined by access to advanced models or the scale of experimentation, but by an organization’s ability to operationalize AI reliably within core workflows. This report examines how AI applications and use cas...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...